Primary immune thrombocytopenia
Clinical trials for Primary immune thrombocytopenia explained in plain language.
Never miss a new study
Get alerted when new Primary immune thrombocytopenia trials appear
Sign up with your email to follow new studies for Primary immune thrombocytopenia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Long-Term platelet control in rare bleeding disorder
Disease control CompletedThis phase 3 trial tested the long-term safety and effectiveness of efgartigimod, an IV drug, in 101 adults with primary immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. Participants received efgartigimod infusions over 52 w…
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Real-World data may reveal which ITP treatments work best
Knowledge-focused CompletedThis study looks back at health records from over 3,700 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys blood platelets, raising bleeding risk. Researchers want to see which second-line treatments doctors prescribe after first-line steroids…
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
ITP study reveals hidden toll on brain and body
Knowledge-focused CompletedThis study looked at how chronic immune thrombocytopenia (ITP) affects thinking skills and fatigue in adults. Researchers measured brain function and inflammation using blood tests and questionnaires in 97 patients. The goal was to better understand these connections, not to test…
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC